Cargando…

Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection

BACKGROUND: In areas where malaria endemicity is high, many people harbour blood stage parasites without acute febrile illness, complicating the estimation of disease burden from infection data. For Plasmodium falciparum the density of parasitaemia that can be tolerated is low in the youngest childr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Ivo, Genton, Blaise, Rare, Lawrence, Kiniboro, Benson, Kastens, Will, Zimmerman, Peter, Kazura, James, Alpers, Michael, Smith, Thomas A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719654/ https://www.ncbi.nlm.nih.gov/pubmed/19602275 http://dx.doi.org/10.1186/1475-2875-8-158

Ejemplares similares

Plasmodium vivax and Mixed Infections Are Associated with Severe Malaria in Children: A Prospective Cohort Study from Papua New Guinea
por: Genton, Blaise, et al.
Publicado: (2008)

Reduced Plasmodium vivax Erythrocyte Infection in PNG Duffy-Negative Heterozygotes
por: Kasehagen, Laurin J., et al.
Publicado: (2007)

Molecular epidemiology of force of infection in malaria
por: Felger, Ingrid, et al.
Publicado: (2010)

IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children
por: França, Camila T., et al.
Publicado: (2017)

The epidemiology of Plasmodium falciparum and Plasmodium vivax in East Sepik Province, Papua New Guinea, pre- and post-implementation of national malaria control efforts
por: Kattenberg, Johanna H., et al.
Publicado: (2020)

Rifampicin/Cotrimoxazole/Isoniazid Versus Mefloquine or Quinine + Sulfadoxine- Pyrimethamine for Malaria: A Randomized Trial
por: Genton, Blaise, et al.
Publicado: (2006)

Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodiumvivax drug resistance in two regions from Papua New Guinea
por: Barnadas, Céline, et al.
Publicado: (2015)

Features and Prognosis of Severe Malaria Caused by Plasmodium falciparum, Plasmodium vivax and Mixed Plasmodium Species in Papua New Guinean Children
por: Manning, Laurens, et al.
Publicado: (2011)

Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria
por: Mazhari, Ramin, et al.
Publicado: (2023)

Multiplicity and Diversity of Plasmodium vivax Infections in a Highly Endemic Region in Papua New Guinea
por: Koepfli, Cristian, et al.
Publicado: (2011)

Efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria in Papua New Guinea
por: Tavul, Livingstone, et al.
Publicado: (2018)

High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea
por: Mueller, Ivo, et al.
Publicado: (2009)

The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New Guinea
por: Hofmann, Natalie E, et al.
Publicado: (2017)

Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping
por: Schoepflin, Sonja, et al.
Publicado: (2009)

Co-infection of the four major Plasmodium species: Effects on densities and gametocyte carriage
por: Holzschuh, Aurel, et al.
Publicado: (2022)

Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea
por: Tisch, Daniel J., et al.
Publicado: (2011)

Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania
por: Mugittu, Kefas, et al.
Publicado: (2006)

Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate–high malaria transmission intensity
por: Tayipto, Yanie, et al.
Publicado: (2022)

Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review
por: D'Acremont, Valérie, et al.
Publicado: (2010)

Mass drug administration for malaria elimination: do we understand the settings well enough?
por: Hetzel, Manuel W., et al.
Publicado: (2018)

A prospective cohort study of Plasmodium falciparum malaria in three sites of Western Kenya
por: Ondeto, Benyl M., et al.
Publicado: (2022)

A High Force of Plasmodium vivax Blood-Stage Infection Drives the Rapid Acquisition of Immunity in Papua New Guinean Children
por: Koepfli, Cristian, et al.
Publicado: (2013)

The Synthetic Plasmodium falciparum Circumsporozoite Peptide PfCS102 as a Malaria Vaccine Candidate: A Randomized Controlled Phase I Trial
por: Audran, Régine, et al.
Publicado: (2009)

High Rates of Asymptomatic, Sub-microscopic Plasmodium vivax Infection and Disappearing Plasmodium falciparum Malaria in an Area of Low Transmission in Solomon Islands
por: Waltmann, Andreea, et al.
Publicado: (2015)

The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea
por: Marfurt, Jutta, et al.
Publicado: (2008)

Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria
por: He, Wen-Qiang, et al.
Publicado: (2019)

A review of malaria vaccine clinical projects based on the WHO rainbow table
por: Schwartz, Lauren, et al.
Publicado: (2012)

Plasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean Children
por: França, Camila T., et al.
Publicado: (2016)

Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance
por: Marfurt, Jutta, et al.
Publicado: (2010)

Comparison of detection methods to estimate asexual Plasmodium falciparum parasite prevalence and gametocyte carriage in a community survey in Tanzania
por: Mwingira, Felista, et al.
Publicado: (2014)

Measuring force of infection and vaccine effects on transmission stages in clinical trials of experimental malaria vaccines
por: Felger, Ingrid, et al.
Publicado: (2012)

Self-diagnosis of malaria by travellers: a cohort study on the use of malaria rapid diagnostic tests provided by a Swiss travel clinic
por: Berthod, Delphine, et al.
Publicado: (2017)

Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children
por: Kurtovic, Liriye, et al.
Publicado: (2018)

Similar Prevalence of Plasmodium falciparum and Non–P. falciparum Malaria Infections among Schoolchildren, Tanzania
por: Sendor, Rachel, et al.
Publicado: (2023)

Genetic polymorphisms in the circumsporozoite protein of Plasmodium malariae show a geographical bias
por: Saralamba, Naowarat, et al.
Publicado: (2018)

Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trial
por: Sottas, Oriane, et al.
Publicado: (2019)

Three Divergent Subpopulations of the Malaria Parasite Plasmodium knowlesi
por: Divis, Paul C.S., et al.
Publicado: (2017)

Recommendations for malaria prevention in moderate to low risk areas: travellers’ choice and risk perception
por: Voumard, Rachel, et al.
Publicado: (2015)

Low quality of routine microscopy for malaria at different levels of the health system in Dar es Salaam
por: Kahama-Maro, Judith, et al.
Publicado: (2011)

Safety of falciparum malaria diagnostic strategy based on rapid diagnostic tests in returning travellers and migrants: a retrospective study
por: Rossi, Isabelle Anne, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hheq1k8g2ldicdek08qoa7mrmm